The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
You are here Home Guidance and resources Sponsors Galderma Australia Pty Ltd Regulatory activities for this sponsor. Listen Print Share Loading... Type Prescription medicine decision summary (1) (-) Prescription medicine decision summary (1) Prescription medicine evaluation (1) (-) Prescription medicine evaluation (1) ARTG (50) ARTG (50) Cancellation by sponsor (47) Cancellation by sponsor (47) Australian Public Assessment Report (AusPAR) (5) Australian Public Assessment Report (AusPAR) (5) Prescription medicine registration (1) Prescription medicine registration (1) Show more Date 2024 (1) 2024 (1) 2021 (1) 2021 (1) Search Filters applied:Prescription medicine decision summaryPrescription medicine evaluationClear all Sponsor content2 result(s) found, displaying 1 to 2 Nemluvio Galderma Australia Pty Ltd May-2024 Prescription medicine evaluation Active ingredient: nemolizumab. Aklief 28 January 2021 Prescription medicine decision summary Australian prescription medicine decision summary
Nemluvio Galderma Australia Pty Ltd May-2024 Prescription medicine evaluation Active ingredient: nemolizumab.
Aklief 28 January 2021 Prescription medicine decision summary Australian prescription medicine decision summary